Colossal Biosciences Genetically Engineers Dire Wolves
Analysis based on 8 articles · First reported Apr 07, 2025 · Last updated Apr 08, 2025
The advancements by Colossal Biosciences in genetic engineering and cloning could open new avenues for biotechnology investments and conservation efforts. While the immediate financial market impact is limited, successful de-extinction and species conservation technologies could attract significant funding and partnerships in the long term.
Colossal Biosciences has successfully genetically engineered three wolf pups to resemble extinct dire wolves, using CRISPR technology on gray wolf blood cells and domestic dog surrogates. These pups, aged three to six months, exhibit physical traits like long white hair and muscular jaws, aiming to reach 140 pounds at maturity. However, independent scientists like Vincent Lynch caution that this effort creates superficial resemblances and that dire wolves cannot fulfill their original ecological roles in modern landscapes. Colossal Biosciences also cloned four red wolves to increase genetic diversity in the endangered population, a less invasive technique praised by experts like Bong Go for its conservation potential. Ben Lamm, CEO of Colossal Biosciences, met with the United States — United States Department of the Interior, and Secretary Doug Burgum lauded the scientific progress.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard